🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today we announced a 10-year #biomanufacturing partnership with a leading #pharmaceutical company to support their portfolio. The first product will be manufactured at Resilience’s newly acquired site in #Cincinnati, OH. Learn more: hubs.ly/Q01CzM0t0

Today we announced that we have been approved for $410 million in long-term loan financing from the DoD, working with the U.S. DFC. Read more here: hubs.ly/Q01J6xxP0

Our CEO, Rahul Singhvi, spoke with Steve Usdin about Resilience's $410M financing from the Department of Defense, in partnership with the Development Finance Corporation. Read more about their conversation on BioCentury here: hubs.ly/Q01Jh41P0

Check out Tyler Patchen conversation with our CEO Rahul Singhvi about Resilience's recent $410M financing from the Department of Defense, in partnership with the Development Finance Corporation. Read more about their discussion on Endpoints here: bit.ly/3nsfAZE

“Amid a spate of drug production pledges from the White House, U.S.-based manufacturer National Resilience has scored new government financing to keep its mission running for the long haul.” - Fraiser Kansteiner Read more about our recent news on Fierce Pharma: bit.ly/3KhT1Qk

Going to be at the International Consortium for Advanced Medicines Manufacturing (ICAMM)? On Friday, April 28, please join our CEO, @Rsinghvi, as he discusses “The Role of CDMOs in Addressing Future Challenges Through the Use of Advanced Manufacturing Technologies.”

Proud that biomanufacturer Resilience has adopted our REBEL at-line media analyzer to gain insights into cell metabolism, speed development and reduce cost of goods in a perfusion bioreactor process. Great to work with the Resilience team! Learn more: info.908devices.com/corp0426233

We look forward to seeing you at Pharma Manufacturing World Summit tomorrow. Stop by booth #21 to learn how we strive to future-proof your biomanufacturing. #PMWS23 #biomanufacturing #Resilience

On this #MemorialDay, Resilience honors and remembers the brave men and women who have made the ultimate sacrifice in service to our country. We are grateful for their service and will never forget their sacrifice.

June 19th, #Juneteenth, is significant day for African Americans and for this nation. A powerful reminder of the importance of equity in this country, which is embedded in our mission - to enable equitable access to life saving vaccines and medicines.

Today, we celebrate the beauty, diversity, and rich history of the great country of Canada – Home to our Mississauga facility! Wishing everyone a safe and enjoyable holiday with friends and family. #CanadaDay #CelebrateCanada #WeAreResilience

Happy #IndependenceDay from Resilience! 🇺🇸 As we celebrate the spirit of freedom, we thank those who contribute to our company's journey. Together with our employees, partners, and clients that we will continue to make a positive impact for patients in this country, and beyond.

NEWS: We’re excited to announce a strategic collaboration with BridgeBio Pharma to manufacture and advance their lead investigational gene therapy treatments, BBP-812 and BBP-631. Learn more here: hubs.ly/Q0246w0r0

Join us in San Francisco, CA! Today we announced that our Chief Executive Officer of Resilience, Rahul Singhvi, Sc.D., will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 11:00 a.m. PST. hubs.ly/Q02fdJkj0

We are excited to announce the appointment of Steven Hagen, PhD, as Resilience’s Chief Manufacturing Officer, where his leadership spans our entire cGMP network. Please join us in welcoming Steven to Resilience!

Today is #WorldCancerDay. As a technology-focused biomanufacturing company, we are proud to support multiple partners within the oncology space. We remain committed to working alongside our partners to provide lifesaving treatments for cancer patients.

News! We’re expanding our drug product manufacturing capabilities with a $225M investment in Cincinnati facility, plus expansion in RTP. Read more: hubs.ly/Q02lD1ZS0 #Biomanufacturing #DrugDevelopment

This #RareDiseaseDay, we are honored to partner with BridgeBio Pharma, as together we remain dedicated to accelerating the development of innovative therapies for families living with Canavan disease and congenital adrenal hyperplasia. Learn more:hubs.ly/Q02m7dxY0

We are honored to receive the James A. Wuenker Growth Award from REDI Cincinnati as a result of the expansion we announced in December 2023 to our West Chester, Ohio biomanufacturing site. Learn more: hubs.ly/Q02qWNwz0